Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
MI to Weigh Ban on Stock Buybacks for Companies Receiving Tax Breaks Michigan Sen. Mallory McMorrow (D) introduced a bill ( SB 783 ) that would prohibit publicly traded companies receiving economic incentives...
VA House Passes Paid Sick Leave Bill Virginia’s House of Delegates approved a bill ( HB 5 ) that would expand the state’s current paid sick leave law, which applies only to a small segment...
VA Lawmakers Okay Prescription Drug Affordability Board Virginia lawmakers have passed legislation ( SB 271 / HB 483 ) that would create a prescription drug affordability board to review drug prices...
Geolocation data has become a new frontier in privacy protection. This year, Virginia could join Maryland and Oregon as the first states to prohibit the sale of information that provides the precise...
Insurance Bill Raises Concerns in FL A fast-moving bill ( SB 1028 ) in Florida, sponsored by Sen. Joe Gruters (R), chairman of the Senate’s Banking and Insurance Committee, would require Citizens...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
On the last day of this year’s regular session, California lawmakers passed a bill (SB 525) that would phase in a nation-leading $25 minimum wage for workers at hospitals, nursing homes, and other medical facilities. Gov. Gavin Newsom (D) has until Oct. 14 to act on the measure. (KFF HEALTH NEWS, STATE NET)
At a virtual townhall last week Maryland Del. Joseline Pena-Melnyk (D), chair of her chamber’s Health and Government Operations Committee; U.S. Sen. Chris Van Hollen (D-MD); and the advocacy groups Healthcare for All! and AARP announced their support for legislation next year to establish upper payment limits on some prescription drugs covered by private insurance plans. The planned measure would expand the authority of the state’s Prescription Drug Affordability Board, which is now working on establishing payment limits for drugs covered by public insurance plans. (WYPR)
Benefit consultants from Mercer, Aon and Willis Towers Watson are forecasting U.S. employer healthcare costs to jump 8.5% next year—the largest increase in a decade—due to medical inflation, high demand for expensive weight-loss drugs and expanded access to costly gene therapies. But with the tight labor market, most employers aren’t planning to shift that cost increase onto workers. Beth Umland, Mercer’s director of health & benefits research, said employers “don’t want to add more financial stress on employees who are also coping with inflation, especially in this time where they’re really relying on their health benefits as a way to keep employees working for them.” (REUTERS)
—Compiled by SNCJ Managing Editor KOREY CLARK
Please visit our webpage to connect with a State Net® representative and learn how the State Net legislative and regulatory tracking solution can help you identify, track, analyze and report on relevant legislative and regulatory developments.